全文获取类型
收费全文 | 2438篇 |
免费 | 272篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 57篇 |
儿科学 | 78篇 |
妇产科学 | 61篇 |
基础医学 | 388篇 |
口腔科学 | 76篇 |
临床医学 | 210篇 |
内科学 | 606篇 |
皮肤病学 | 55篇 |
神经病学 | 184篇 |
特种医学 | 111篇 |
外科学 | 267篇 |
综合类 | 117篇 |
一般理论 | 21篇 |
预防医学 | 153篇 |
眼科学 | 76篇 |
药学 | 118篇 |
中国医学 | 1篇 |
肿瘤学 | 139篇 |
出版年
2023年 | 20篇 |
2022年 | 31篇 |
2021年 | 58篇 |
2020年 | 28篇 |
2019年 | 42篇 |
2018年 | 66篇 |
2017年 | 43篇 |
2016年 | 34篇 |
2015年 | 53篇 |
2014年 | 64篇 |
2013年 | 106篇 |
2012年 | 138篇 |
2011年 | 148篇 |
2010年 | 76篇 |
2009年 | 83篇 |
2008年 | 132篇 |
2007年 | 130篇 |
2006年 | 103篇 |
2005年 | 114篇 |
2004年 | 103篇 |
2003年 | 78篇 |
2002年 | 88篇 |
2001年 | 34篇 |
2000年 | 51篇 |
1999年 | 40篇 |
1998年 | 34篇 |
1997年 | 25篇 |
1996年 | 22篇 |
1995年 | 18篇 |
1994年 | 22篇 |
1993年 | 16篇 |
1992年 | 37篇 |
1991年 | 36篇 |
1990年 | 18篇 |
1989年 | 22篇 |
1988年 | 27篇 |
1987年 | 32篇 |
1986年 | 19篇 |
1985年 | 23篇 |
1984年 | 16篇 |
1983年 | 21篇 |
1981年 | 29篇 |
1979年 | 31篇 |
1978年 | 22篇 |
1976年 | 27篇 |
1975年 | 31篇 |
1974年 | 30篇 |
1973年 | 18篇 |
1967年 | 14篇 |
1966年 | 14篇 |
排序方式: 共有2718条查询结果,搜索用时 31 毫秒
91.
Assimakopoulos SF Thomopoulos KC Louvros E Theocharis G Giannikoulis C Katsakoulis E Nikolopoulou VN 《The American journal of the medical sciences》2008,336(1):21-26
BACKGROUND: During the past years, major advances in the management of upper gastrointestinal diseases have been achieved. The aim of this study was to determine if changes in indications for upper gastrointestinal endoscopy and endoscopic findings have occurred during the last 15 years in our area. METHODS: Indications for upper gastrointestinal tract endoscopy and endoscopy findings of patients who underwent upper endoscopy in years 1990, 1995, 2000, and 2005 in our department were compared. RESULTS: Over the 15-year period, the number of diagnostic endoscopies performed in our department in years 1990, 1995, 2000, and 2005 increased (953, 1245, 2350, and 2528, respectively). Acute upper gastrointestinal bleeding had become less frequent (40%, 42.8%, 19.7%, 14.3%, P<0.001), but dyspepsia (24.4%, 33.6%, 54.3%, 51.3%, P=0.002) and reflux (1.8%, 1.3%, 5.1%, 10.8%, P=0.005) more frequent indications for upper endoscopy. The endoscopic findings of duodenal ulcer (39.1%, 22.5%, 20.5%, 9.3%, P<0.001), gastric ulcer (15.9%, 8.3%, 5.7%, 4.6%, P=0.036) as well as erosive gastroduodenitis (35.6%, 22.2%, 15.3%, 4.7%, P<0.001) decreased, whereas that of reflux esophagitis (3.1%, 10.1%, 12%, 16%, P=0.034) increased. Moreover, the percentage of patients with negative endoscopy or minimal endoscopic findings (eg, nonerosive gastritis) increased (12.8%, 33.7%, 54.1%, 64.4%, P<0.001). CONCLUSIONS: In south-western Greece, dyspepsia and reflux as an indication for upper endoscopy have been increasing, whereas acute upper gastrointestinal bleeding has been decreasing. The finding of peptic ulcers at the upper gastrointestinal tract endoscopy has become significantly less frequent, while the percentage of patients with negative results of endoscopy seems to have been increasing rapidly. 相似文献
92.
Emanuel Raschi Igor Diemberger Benilde Cosmi Fabrizio De Ponti 《Internal and emergency medicine》2018,13(1):1-9
The recent position paper of the European Society of Cardiology (ESC) on cardiovascular toxicity of cancer treatments has attracted considerable interest by healthcare professionals, since it is the first concrete help in the difficult task of monitoring and approaching cardiovascular side effects of anticancer treatments. The ESC expert opinion was not intended as a clinical practice guideline; however, it reports major cardiovascular complications grouped into nine categories, addressing current clinical strategies for prevention and mitigation. In this point of view, we discuss key challenges emerging from critical appraisal of the ESC position paper: (1) the wide spectrum of cardiovascular toxicities associated with oncological drugs, focusing on targeted agents, (2) managing strategies in patients with cardiac implantable devices, (3) the underappreciated (but emerging) immune-related cardiovascular toxicities of checkpoint inhibitors, which may also result in severe heart failure and fulminant myocarditis, (4) the evolving role of anticoagulation in oncology, and the evidence supporting (or not) the use of direct-acting oral anticoagulants in cancer-associated thrombosis. 相似文献
93.
Meng Niu Brenda Morsey Benjamin G. Lamberty Katy Emanuel Fang Yu Rosiris Len-Rivera Joan W. Berman Peter J. Gaskill Stephanie M. Matt Pawel S. Ciborowski Howard S. Fox 《Viruses》2020,12(11)
Both substance use disorder and HIV infection continue to affect many individuals. Both have untoward effects on the brain, and the two conditions often co-exist. In the brain, macrophages and microglia are infectable by HIV, and these cells are also targets for the effects of drugs of abuse, such as the psychostimulant methamphetamine. To determine the interaction of HIV and methamphetamine, we isolated microglia and brain macrophages from SIV-infected rhesus monkeys that were treated with or without methamphetamine. Cells were subjected to single-cell RNA sequencing and results were analyzed by statistical and bioinformatic analysis. In the animals treated with methamphetamine, a significantly increased proportion of the microglia and/or macrophages were infected by SIV. In addition, gene encoding functions in cell death pathways were increased, and the brain-derived neurotropic factor pathway was inhibited. The gene expression patterns in infected cells did not cluster separately from uninfected cells, but clusters comprised of microglia and/or macrophages from methamphetamine-treated animals differed in neuroinflammatory and metabolic pathways from those comprised of cells from untreated animals. Methamphetamine increases CNS infection by SIV and has adverse effects on both infected and uninfected microglia and brain macrophages, highlighting the dual and interacting harms of HIV infection and drug abuse on the brain. 相似文献
94.
95.
96.
Calvaruso V Dhillon AP Tsochatzis E Manousou P Grillo F Germani G Patch D O'Beirne J Burroughs AK 《Journal of gastroenterology and hepatology》2012,27(7):1227-1232
Background and Aims: Current histological scoring systems do not subclassify cirrhosis. Computer‐assisted digital image analysis (DIA) of Sirius Red‐stained sections measures fibrosis morphologically producing a fibrosis ratio (collagen proportionate area [CPA]). CPA could have prognostic value within a disease stage, such as cirrhosis. The aim of the present study was to evaluate CPA in patients with recurrent hepatitis C virus (HCV) allograft cirrhosis and assess its relationship with hepatic venous pressure gradient (HVPG). Methods: In 121 consecutively‐transplanted HCV patients with HVPG, measured contemporaneously with transjugular liver biopsies, 65 had Ishak stage 5 or 6 disease (43 with HVPG measurement). Biopsies were stained with Sirius Red for DIA, and the collagen content was expressed as a CPA. In three cases, a tissue for Sirius Red staining was not obtained, and the patients were excluded. Results: Sixty‐two patients were analyzed. The median HVPG was 8 mmHg (interquartile range [IQR]: 5–10). Portal hypertension (HVPG ≥ 6 < 10 mmHg) was present in 30 (69.8%), and HVPG ≥ 10 mmHg in 13 (30.2%). The median CPA was 16% (IQR 10.75–23.25). Median Child–Pugh score and HVPG were not significantly different between Ishak fibrosis stage 5 or 6, whereas CPA was statistically different: 13% in stage 5 (IQR 8.3–12.4) versus 23% in stage 6 (IQR 17–33.7, P < 0.001). In the multivariate analysis, CPA was the only variable significantly associated with clinically‐significant portal hypertension (HVPG ≥ 10 mmHg, odds ratio: 1.085, confidence interval: 1.004–1.172, P = 0.040). A CPA of 14% was the best cut‐off value for clinically‐significant portal hypertension (CSPH) and liver decompensation, which occurred in 24 patients. Event‐free survival was significantly shorter in patients with CSPH or with a CPA value ≥ 14%, or with a combination of both. Conclusion: In Ishak stages 5 and 6, CPA correlated with HVPG, but had a wider range of values, suggesting a greater sensitivity for distinguishing “early” from “late” severe fibrosis/cirrhosis. CPA was a unique, independent predictor of HVPG ≥ 10 mmHg. CPA can be used to subclassify cirrhosis and for prognostic stratification. 相似文献
97.
Mary H Hodges Nsa Dada Anna Warmsley Jusufu Paye Momodu M Bangura Emanuel Nyorkor Mustapha Sonnie Yaobi Zhang 《BMC infectious diseases》2012,12(1):16
Background
The first-ever round of school-based mass drug administration (MDA) with praziquantel together with mebendazole targeting school-aged children in endemic districts was conducted in 2009 by the National Neglected Tropical Diseases Control Program. To evaluate the impact of the treatment regimen, a cross-sectional sentinel site survey was conducted 6 months post-MDA. 相似文献98.
Jakob Kristian Jakobsen Elias Raja Zakharia Anders Kindberg Boysen Henning Andersen Friedrich Emanuel Schlesinger Lars Lund 《International journal of urology》2013,20(7):734-737
We present a case of a previously healthy and active 64‐year‐old man who experienced a rapid neuropsychiatric decline. All tests for metabolic causes, neuroinfection, intracranial infarction or tumor were negative. By the means of magnetic resonance imaging, electroencephalography and the anti‐Hu antibody test the patient was diagnosed with paraneoplastic limbic encephalitis related to prostate cancer. The patient died within 6 months. We review the literature on prostate cancer‐related paraneoplastic limbic encephalitis. High‐risk prostate cancer can trigger paraneoplastic limbic encephalitis, a rapidly progressive neurological syndrome with a bad prognosis. 相似文献
99.
100.